We are thrilled to share our latest research in collaboration with Shenyang Pharmaceutical University! Our study, led by Dr. Chutong Tian, introduces a self-motivated carrier-free nanoplatform that synergizes photodynamic therapy (PDT) and ferroptosis for targeted anticancer treatment.
Journal: Nano Research
Authors: Chutong Tian, Wenjing Ma, Jianbin Shi, Jia Deng, Zeping Gao, Haowen Tian, Ayumi Kikkawa, Kaho Tanaka, Ronggang Xi, Cong Luo, Xiaobo Wang, Ken-ichiro Kamei
🔬 Key Highlights:
✅ Overcomes tumor resistance by combining PDT with ferroptosis-driven therapy
✅ Uses a light-boosted nanoplatform (PLA@R NPs) to trigger precise drug release
✅ Enhances oxidative stress and improves treatment efficacy in a tumor-on-a-chip model
✅ Demonstrates significant in vivo antitumor effects
Our approach addresses the challenges of low oxygen levels and excess glutathione (GSH) in tumor tissues, paving the way for a more effective and tumor-specific treatment strategy.
📖 Read the full study here: [Insert link]
We appreciate the fantastic teamwork and collaboration that made this research possible. Looking forward to discussions and potential collaborations in this exciting area of nanomedicine and cancer therapy!
#CancerTherapy #PhotodynamicTherapy #Ferroptosis #Nanomedicine #TumorOnAChip #BiomedicalResearch #NewPublication
0 Comments